90 related articles for article (PubMed ID: 28272714)
1. Role of DWI assessing nodal involvement and response to neoadjuvant chemotherapy in advanced breast cancer.
Belli P; Bufi E; Buccheri C; Rinaldi P; Giuliani M; Romani M; Fabrizi G; D'angelo A; Brunelli C; Mule' A; Franceschini G; Colosimo C
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):695-705. PubMed ID: 28272714
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
[TBL] [Abstract][Full Text] [Related]
3. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
4. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
6. Preoperative axillary staging with 3.0-T breast MRI: clinical value of diffusion imaging and apparent diffusion coefficient.
Rautiainen S; Könönen M; Sironen R; Masarwah A; Sudah M; Hakumäki J; Vanninen R; Sutela A
PLoS One; 2015; 10(3):e0122516. PubMed ID: 25823016
[TBL] [Abstract][Full Text] [Related]
7. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
[TBL] [Abstract][Full Text] [Related]
8. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
9. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
10. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of diffusion-weighted-MRI in prostate cancer.
Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Axillary Lymph Nodes in a Sample of Iranian Women with Breast Cancer.
Hasanzadeh F; Faeghi F; Valizadeh A; Bayani L
Asian Pac J Cancer Prev; 2017 May; 18(5):1265-1270. PubMed ID: 28610412
[TBL] [Abstract][Full Text] [Related]
14. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
15. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
[TBL] [Abstract][Full Text] [Related]
16. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.
Lee MC; Joh JE; Chau A
Cancer Control; 2012 Oct; 19(4):277-85. PubMed ID: 23037495
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MR imaging of benign and malignant breast lesions before and after contrast enhancement.
Janka R; Hammon M; Geppert C; Nothhelfer A; Uder M; Wenkel E
Rofo; 2014 Feb; 186(2):130-5. PubMed ID: 23929263
[TBL] [Abstract][Full Text] [Related]
18. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ
Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607
[TBL] [Abstract][Full Text] [Related]
19. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer.
Patel NA; Piper G; Patel JA; Malay MB; Julian TB
Am Surg; 2004 Aug; 70(8):696-9; discussion 699-700. PubMed ID: 15328803
[TBL] [Abstract][Full Text] [Related]
20. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
